Project Grant R01CA295898
Award Date
6/3/25
Completion Date
5/31/30
Dollars Obligated
$534K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This $895,779 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) aims to advance the science of brain metastases from HER2-positive breast cancer. The key products and services to be delivered under this 7-year grant include: Understanding the fundamental biology and genetic risk factors of HER2-positive breast cancer metastases to the brain through patient tissue-based research. Developing real-time visualization techniques to track cancer cells and...
This $392,187 Project Grant award from the National Cancer Institute's Cancer Biology Research (CFDA 93.396) program supports research at the University of California, San Diego (UCSD) to investigate how changes in the mechanical properties of the tumor microenvironment contribute to the invasive and metastatic behavior of oral squamous cell carcinoma (OSCC). The project aims to elucidate the mechanisms by which tumor stiffness induces the acquisition and consolidation of "mechanical...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $180,632 to the University of Pittsburgh to conduct research aimed at halting breast cancer metastasis by blocking the engulfment of mesenchymal stem cells (MSCs) by cancer cells. The key objectives are: 1) Discovering and validating compounds that can block the cancer-MSC engulfment process using a high-throughput microfluidic assay and 3D cancer spheroid models, and 2) Unraveling...
This $192,240 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports research conducted by The University of Texas MD Anderson Cancer Center to investigate the functional impact of cancer cell extracellular vesicles (CCEVs) on the tumor microenvironment and their role in pancreatic cancer initiation, progression, and metastasis. The research aims to elucidate the mechanisms of CCEV-mediated intercellular communication and identify novel...
The National Cancer Institute (NCI) awarded a $619,294 Project Grant under CFDA 93.394 "Cancer Detection and Diagnosis Research" to the University of California, San Diego (UCSD) to develop slow-release CPMV (Cowpea Mosaic Virus)-polymer blend formulations for intratumoral immunotherapy delivery. The project aims to formulate CPMV-laden slow-release devices, establish and tune the release rates, confirm the structural integrity and biological activity of the released CPMV, and...
This $447,340 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the University of Miami aims to identify epigenetic dependencies and vulnerabilities in endocrine-resistant breast cancer. The research focuses on investigating the role of the CoREST-SWI/SNF axis in mediating breast cancer cell plasticity and endocrine therapy resistance, particularly in the context of ESR1 and ARID1A mutations. The project will evaluate the effects of CoREST...
The National Cancer Institute (NCI) awarded a $472,921 Project Grant under the Cancer Biology Research (CFDA 93.396) federal grant program to the University of Utah. The 5-year grant, running from February 1, 2025 to January 31, 2030, will support research to understand the molecular mechanisms by which the protein Cripto (CR1) mediates cellular plasticity and heterogeneity in breast cancer progression and metastasis. The project aims to elucidate how CR1 responds to microenvironmental and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $592,500.00 to the University of California, San Diego to develop a "MUTANT DNA-ACTIVATED KILLING SYSTEM FOR PRECISION BREAST CANCER THERAPY." The award has a performance period from February 1, 2025 to January 31, 2028. The project aims to advance innovative biomedical research and transformative healthcare solutions for military service members...
This U01 Cooperative Agreement award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $665,155 in funding to The Johns Hopkins University from September 2024 through August 2029 to conduct research on defining the brain-body feedback loops that mediate stress-induced metastasis in cancer. The key objectives are to: 1) Investigate how glucocorticoids released during stress trigger neutrophil extracellular trap (NET) formation to promote metastasis; 2) Determine...
The National Institutes of Health National Cancer Institute awarded a $366,439.80 Project Grant to the University of California, San Diego to support research identifying and exploiting metabolic vulnerabilities in cancer. The grant supports the work of Thekla Cordes, an expert in dissecting cancer metabolism through metabolic systems biology approaches, who will develop and apply mass spectrometry-based analytical techniques to quantify metabolite levels and metabolic fluxes in diverse cancer...